The city of Las Vegas, Nevada, currently has 3 active clinical trials seeking participants for Parkinson's Disease research studies.
Rostock International Parkinson's Disease Study (ROPAD)
Recruiting
Rostock International Parkinson's Disease Study - An International, multicenter, epidemiological observational study aiming at identification of LRRK2-positive patients, the recruitment of 25,000 PD participants and the establishment of a candidate biomarker in the LRRK2-positive cohort.
Gender:
All
Ages:
Between 30 years and 80 years
Trial Updated:
03/21/2024
Locations: WR-CRCN, Las Vegas, Nevada
Conditions: ParkinsonĀ“s Disease
PPMI Clinical - Establishing a Deeply Phenotyped PD Cohort
Recruiting
The Parkinson Progression Marker Initiative (PPMI) is a longitudinal, observational, multi-center natural history study to assess progression of clinical features, digital outcomes, and imaging, biologic and genetic markers of Parkinson's disease (PD) progression in study participants with manifest PD, prodromal PD, and healthy controls. The overall goal of PPMI is to identify markers of disease progression for use in clinical trials of therapies to reduce progression of PD disability.
Gender:
All
Ages:
30 years and above
Trial Updated:
12/13/2023
Locations: Cleveland Clinic Lou Ruvo Center for Brain Health, Las Vegas, Nevada
Conditions: Parkinson Disease
Parkinson's Research With Inclusion, Diversity and Equity
Recruiting
The purpose of this study is to identify the health and healthcare needs of LGBTQIA+ and non LGBTQIA+ communities living with Parkinson's disease.
Gender:
All
Ages:
18 years and above
Trial Updated:
10/05/2022
Locations: University of Nevada, Las Vegas, Las Vegas, Nevada
Conditions: Parkinson Disease